- CEO
- Hong Jian Zhuo
- Full Time Employees
- 990
- Sector
- Consumer non-durables
- Industry
- Food: specialty/candy
- Address
- National High-tech Industrial Development Zone Dezhou China 251200
- IPO Date
- Apr 21, 2021
- Business
- Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of functional sugars, dietary fibers, prebiotics, and healthy sweeteners. Its product portfolio includes prebiotic fibers such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide; dietary fibers like polydextrose and resistant dextrin; and starch sugars including allulose, maltitol, maltodextrin, allulose psicose, and isomaltulose available in powder and syrup forms. The company's products cater primarily to the food, pharmaceutical, health product, and feed industries. Founded in 2005 and headquartered in Yucheng, Shandong Province, China, it operates globally across Asia, Africa, Europe, Australia, and the Americas.
Recent strategic initiatives include expanding its allulose product portfolio with a crystalline form certified as Non-GMO Project Verified to meet growing market demand for healthier sugar alternatives. The company is investing approximately CNY 452 million (USD 61.8 million) in building an artificial sweetener factory in Thailand to reduce trade barriers and production costs, particularly targeting the U.S. market. It also concluded a funding round providing THB 105 million for its subsidiary Bailong Chuangyuan (Thailand) Co., Ltd., supporting regional expansion. New acquisitions of two local biotechnology firms have bolstered its revenue base and enhanced its technological capabilities. The company emphasizes sustainability through investments in green production technologies and maintains certifications including BRCGS, ISO, HALAL, KOSHER, Non-GMO, and Organic.
Shandong Bailong Chuangyuan integrates R&D, manufacturing, sales, and service, serving major customers such as Unilever, Mars, and Nestle. The company covers a production area of over 139,000 square meters, with an annual capacity of 300,000 tons and employs around 900 staff. It is recognized as a high-tech enterprise and a flagship entity in China’s functional sugar industry and bioengineering sector, with a strong focus on innovative health ingredient solutions and global market development.